Your browser doesn't support javascript.
loading
From circuits to behavior: Amygdala dysfunction in fragile X syndrome.
Svalina, Matthew N; Sullivan, Regina; Restrepo, Diego; Huntsman, Molly M.
Afiliação
  • Svalina MN; Medical Scientist Training Program, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Sullivan R; Neuroscience Graduate Program, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Restrepo D; Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Huntsman MM; Department of Cell and Developmental Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Front Integr Neurosci ; 17: 1128529, 2023.
Article em En | MEDLINE | ID: mdl-36969493
Fragile X syndrome (FXS) is a neurodevelopmental disorder caused by a repeat expansion mutation in the promotor region of the FMR1 gene resulting in transcriptional silencing and loss of function of fragile X messenger ribonucleoprotein 1 protein (FMRP). FMRP has a well-defined role in the early development of the brain. Thus, loss of the FMRP has well-known consequences for normal cellular and synaptic development leading to a variety of neuropsychiatric disorders including an increased prevalence of amygdala-based disorders. Despite our detailed understanding of the pathophysiology of FXS, the precise cellular and circuit-level underpinnings of amygdala-based disorders is incompletely understood. In this review, we discuss the development of the amygdala, the role of neuromodulation in the critical period plasticity, and recent advances in our understanding of how synaptic and circuit-level changes in the basolateral amygdala contribute to the behavioral manifestations seen in FXS.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article